| Literature DB >> 35457379 |
Natalia Cantó-Sancho1, Elena Ronda2,3, Julio Cabrero-García4, Stefano Casati5, Angela Carta6,7, Stefano Porru6,7, Mar Seguí-Crespo1,2.
Abstract
The use of digital devices affects eye health; this can influence the performance of workers. To assess this impact, validated patient-reported outcome questionnaires are needed. The purpose of this study was to validate the psychometric properties of the Italian version of the Computer Vision Syndrome Questionnaire (CVS-Q©) using Rasch analysis. Two hundred and forty-one Italian workers completed an ad hoc questionnaire on anamnesis and exposure to digital devices, and the Italian version of the CVS-Q©. Subsequently, a battery involving three clinical ocular surface and tear tests was performed. The reliability and validity of the scale was assessed using the Andrich Rating Scale Model, and the prevalence of computer vision syndrome (CVS) was calculated. A good fit of both items and persons to the predictions of the Rasch model was observed, with acceptable reliability, unidimensionality, and no or minimal severe differences as a function of gender or age; moreover, good test-retest repeatability, adequate values of sensitivity, reliability, and area under the curve, and adequate construct validity based on clinical tests were obtained. Workers with a questionnaire score ≥ 7 were found to present with CVS. The prevalence of CVS was 76.6%. The CVS-Q IT© is a valid and reliable scale to assess CVS in Italian workers who use digital devices.Entities:
Keywords: Rasch model; asthenopia; psychometrics; surveys and questionnaires; validation study
Mesh:
Year: 2022 PMID: 35457379 PMCID: PMC9028942 DOI: 10.3390/ijerph19084506
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Reasons for exclusion of the participants.
| Reason for Exclusion | N |
|---|---|
| Daily use of contact lenses | 6 |
| Prior refractive surgery | 8 |
| Prior cataract surgery | 4 |
| Ocular pathology at the time of the study | 20 |
| Ocular pharmacological treatment at the time of the study | 8 |
| Failure to perform the battery of clinical tests | 9 |
| Total | 55 |
Sociodemographic characteristics and exposure to digital devices of the study sample.
| N | % | |
|---|---|---|
| Total | 241 | 100 |
| Gender | ||
| Female | 155 | 64.3 |
| Male | 86 | 35.7 |
| Age (years) | ||
| ≤35 | 52 | 21.6 |
| 36–45 | 55 | 22.8 |
| ≥46 | 134 | 55.6 |
| Occupational use of digital devices (hours/week) | ||
| <20 | 17 | 7.0 |
| ≥20 | 224 | 93.0 |
| Years working with digital devices | ||
| ≤10 | 74 | 30.7 |
| 11–20 | 94 | 39.0 |
| ≥21 | 73 | 30.3 |
| Scheduled breaks during work with digital devices | ||
| No | 34 | 14.1 |
| Yes | 207 | 85.9 |
| Use of digital devices to leisure (hours/day) | ||
| <2 | 130 | 53.9 |
| ≥2 | 111 | 46.1 |
| Total use of digital devices (hours/day) | ||
| ≤4 | 9 | 3.7 |
| 5–8 | 156 | 64.7 |
| >8 | 76 | 31.6 |
Figure 1Category response probability curves for the CVS-Q IT©.
Item Rasch analysis results of the symptom severity scale.
| Item Description | Severity | SE | Infit MNSQ | Outfit MNSQ | Gender DIF Contrast | Age DIF Contrast | Version DIF Contrast |
|---|---|---|---|---|---|---|---|
| 1. Burning | −0.61 | 0.13 | 0.73 | 0.70 | 0.12 | 0.10 | * 1.30 |
| 2. Itching | −0.24 | 0.14 | 0.93 | 0.94 | 0.76 | 0.00 | * 1.31 |
| 3. Feeling of a foreign body | 0.60 | 0.15 | 0.93 | 0.86 | 0.26 | 0.29 | 0.52 |
| 4. Tearing | 0.06 | 0.14 | 1.10 | 1.10 | 0.29 | 0.16 | 0.25 |
| 5. Excessive blinking | 0.79 | 0.16 | 0.95 | 0.94 | 0.47 | 0.36 | 0.19 |
| 6. Eye redness | −0.15 | 0.14 | 1.00 | 1.06 | 0.90 | 0.29 | 0.67 |
| 7. Eye pain | 1.99 | 0.21 | 1.03 | 0.82 | 0.10 | 0.49 | * 1.35 |
| 8. Heavy eyelids | −0.49 | 0.13 | 0.99 | 1.01 | 0.18 | 0.68 | 0.72 |
| 9. Dryness | −0.33 | 0.13 | 1.14 | 1.05 | 0.73 | 0.15 | 0.08 |
| 10. Blurred vision | −1.07 | 0.13 | 0.87 | 0.87 | 0.03 | 0.18 | 0.31 |
| 11. Double vision | 1.38 | 0.18 | 1.02 | 0.86 | 0.25 | 0.05 | * 1.41 |
| 12. Difficulty focusing for near vision | −0.72 | 0.13 | 1.14 | 1.19 | 0.20 | * 1.58 | 0.19 |
| 13. Increased sensitivity to light | −0.78 | 0.13 | 1.25 | 1.23 | 0.62 | 0.15 | 0.47 |
| 14. Coloured halos around objects | 1.51 | 0.19 | 0.91 | 0.76 | 0.29 | 0.13 | 0.39 |
| 15. Feeling that sight is worsening | −1.09 | 0.13 | 0.84 | 0.81 | 0.36 | 0.51 | 0.20 |
| 16. Headache | −0.85 | 0.13 | 1.18 | 1.23 | 0.32 | 0.61 | 0.45 |
MNSQ, mean square error; DIF, differential item functioning. * p ≤ 0.003 (Bonferroni correction).
Figure 2Information function of the CVS-Q IT©.
Figure 3Item–person map for the CVS-Q IT©.
Raw score in the CVS-Q IT© questionnaire and its conversion to logits.
| Raw Score | Rasch Score (Logits) | Raw Score | Rasch Score (Logits) |
|---|---|---|---|
| 0 | −6.05 E | 17 | 0.24 |
| 1 | −4.78 | 18 | 0.47 |
| 2 | −4.00 | 19 | 0.70 |
| 3 | −3.50 | 20 | 0.93 |
| 4 | −3.11 | 21 | 1.16 |
| 5 | −2.78 | 22 | 1.39 |
| 6 | −2.48 | 23 | 1.63 |
| 7 | −2.20 | 24 | 1.88 |
| 8 | −1.94 | 25 | 2.15 |
| 9 | −1.69 | 26 | 2.43 |
| 10 | −1.44 | 27 | 2.75 |
| 11 | −1.19 | 28 | 3.11 |
| 12 | −0.94 | 29 | 3.53 |
| 13 | −0.70 | 30 | 4.07 |
| 14 | −0.46 | 31 | 4.90 |
| 15 | −0.22 | 32 | 6.20 E |
| 16 | 0.01 |
Figure 4Receiver operator characteristic curve of the CVS-Q IT©.
Figure 5Percentage of workers who presented each symptom according to frequency and intensity.